MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy
BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.
It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.
You may also like
Gainers
Latest Crypto News
Analysis: The main reason for the recent cryptocurrency market crash was the Bank of Japan hinting at a rate hike and market concerns about a potential "Strategy" disaster.
Paradigm's associated wallet sent 6300 ETH to Coinbase
Coinbase Executive Sued by Shareholders for Alleged $4.2 Billion Insider Trading
An address holding 50 BTC has just been activated after being dormant for 15.7 years
Pacifica: Users who were liquidated between October 1st and December 1st will receive a 20% bonus on December transactions.
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:bd@weex.com
VIP Services:support@weex.com